Linde plc

“Linde is structurally one of the best businesses in the world — oligopoly-protected, contractually-secured, with a widening moat and decades of reinvestment runway in hydrogen, semiconductors, and healthcare. Management is disciplined and shareholder-aligned with a clean governance record. The sole obstacle to a BUY verdict is price: at 34x trailing earnings and ~20x EV/EBITDA, the market has fully priced the quality, leaving a base-case 10-year return of 6–7% CAGR — respectable but insufficient to compensate for the full price paid. Permanent impairment risk is near-negligible; the risk here is purely opportunity cost. New investors should track for a meaningful pullback toward $420–445 before initiating a position.”